Nuveen’s Sanara MedTech SMTI Stock Holding History

Nuveen’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Sell	11,101 -4,106	-27%	-$84.9K	﹤0.01%	3546
2026 Q1	$261K	Buy	+15,207	New	+$313K	﹤0.01%	3032
2025 Q4	–	Sell	-20,752	Closed	-$658K	–	3294
2025 Q3	$658K	Buy	+20,752	New	+$626K	﹤0.01%	2804
2025 Q2	–	Sell	-10,565	Closed	-$326K	–	3397
2025 Q1	$326K	Buy	+10,565	New	+$359K	﹤0.01%	3015
2024 Q2	–	Sell	-5,537	Closed	-$205K	–	3410
2024 Q1	$205K	Buy	5,537 +448	+9%	+$16.7K	﹤0.01%	3180
2023 Q4	$209K	Buy	+5,089	New	+$163K	﹤0.01%	3208
2023 Q3	–	Sell	-5,089	Closed	-$204K	–	3237
2023 Q2	$204K	Buy	+5,089	New	+$208K	﹤0.01%	3094

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Nuveen's SMTI Position: Q2 2026 in Review

Nuveen reduced its Sanara MedTech (SMTI) stake by 27% in Q2 2026, selling an estimated $84.9K and leaving 11,101 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #3546.

Nuveen first reported a position in SMTI in Q2 2023 and has held it in 7 quarters since. The position peaked at $658K in Q3 2025. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

Nuveen held 11,101 shares of Sanara MedTech worth $262K as of Q2 2026.
Nuveen sold 4,106 Sanara MedTech shares in Q2 2026, an estimated $84.9K.
Sanara MedTech made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3546 holding.
Nuveen first reported a position in Sanara MedTech in Q2 2023 and has held it in 7 quarters since.
Nuveen's Sanara MedTech position peaked at $658K in Q3 2025.
75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.